What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Medical Device

Medical Imaging

PUBLISHER: iData Research Inc. | PRODUCT CODE: 1365524

PUBLISHER: iData Research Inc. | PRODUCT CODE: 1365524

Medical Imaging Device Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: X-Ray Imaging, Breast Imaging, and 5 more

PUBLISHED: October 5, 2023

PAGES: 387 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

In 2023, the U.S. medical imaging market achieved a valuation of $9.0 billion, with a projected growth rate of 2.7% at a Compound Annual Growth Rate (CAGR), the market is anticipated to reach $10.9 billion during the forecast period.

Our comprehensive report suite on the U.S. Medical Imaging Market encompasses a diverse spectrum of over 60 companies in the United States. It encompasses X-ray imaging, breast imaging, magnetic resonance imaging (MRI), ultrasound equipment, computed tomography (CT) imaging, nuclear medicine imaging, and contrast agents and injectors.

MARKET REPORT DATA TYPES INCLUDED:

Unit Sales, Procedure Numbers, Average Selling Prices, Market Size & Growth Trends
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2030, and Historical Data to 2020
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

U.S. Medical Imaging Market Insights

The surge in chronic diseases and the increased recognition of their consequences serve as significant drivers fueling the growth of the imaging market. As chronic illnesses become more prevalent, there is an increasing need for accurate and timely diagnosis, ongoing disease monitoring, and the evaluation of treatment effectiveness. Chronic conditions typically develop slowly, underscoring the crucial role of early detection in effective management. Advanced imaging technologies such as MRI, CT scans, and ultrasound empower healthcare providers to identify the initial signs of chronic diseases before they advance to more severe stages. This early identification enables timely intervention, ultimately leading to improved treatment outcomes and an enhanced quality of life for patients.

U.S. Medical Imaging Market Share Insights

In 2023, GE Healthcare emerged as the frontrunner in the U.S. imaging market, holding a unique position as the sole contender in every imaging segment. GE dominated the X-ray, ultrasound, and nuclear medicine sectors.

Securing the second spot in the overall imaging market for 2023, Siemens Healthineers excelled in the magnetic resonance imaging (MRI) and computed tomography (CT) markets. The company also actively participated in the X-ray, breast imaging, ultrasound, and nuclear medicine markets.

Philips Healthcare, positioned as the third major player in the comprehensive imaging market in 2023, competed across various domains, including X-ray, breast imaging, MRI, ultrasound, and CT markets.

MARKET SEGMENTATION SUMMARY

X-Ray Imaging Market - includes analog, computed radiography (CR), digital radiography (DR), fluoroscopy and cardiovascular X-ray systems.

Breast Imaging Market - includes mammography, molecular breast imaging (MBI), breast ultrasound and breast magnetic resonance imaging (MRI) coil markets.

Magnetic Resonance Imaging Market - includes low-, mid- and high-field MRI systems as well as closed-bore and wide-bore MRIs of any field strength.

Ultrasound Imaging Market - segmented into: equipment for cardiology, radiology, obstetrics and gynecology (OB/GYN), urology, surgery, vascular, ophthalmic and point of care (POC).

Computed Tomography Imaging Market - includes 16/20, 32/40, 64 and ultra-premium slice scanners.

Nuclear Medicine Imaging Market - includes positron emission tomography/computed tomography (PET/CT), single photon emission computed tomography (SPECT) and single photon emission computed tomography/computed tomography (SPECT/CT).

Contrast Agent and Injector Imaging Market - includes X-ray and computed tomography (CT) agents, magnetic resonance imaging (MRI) agents and ultrasound agents as well as contrast injectors.

Research Scope Summary

Report Attribute

Regions: United States
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

Product Code: iDATA_USIMG24

TABLE OF CONTENT

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. MEDICAL IMAGING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURES INCLUDED
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY

RESEARCH METHODOLOGY

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

IMPACT OF COVID-19 ON THE U.S. MEDICAL IMAGING MARKET

2.1. INTRODUCTION
2.2. ANALYSIS BY MARKET SEGMENT
- 2.2.1. Worst Case Scenario
- 2.2.2. Base Case Scenario
- 2.2.3. Best Case Scenario

PRODUCT ASSESSMENT

3.1. INTRODUCTION
3.2. PRODUCT PORTFOLIOS
- 3.2.1. X-ray Imaging Market
  - 3.2.1.1. Analog X-ray Devices
  - 3.2.1.2. Computed Radiography X-ray Devices
  - 3.2.1.3. Digital Radiography X-ray Devices
  - 3.2.1.4. Fluoroscopy Devices
  - 3.2.1.5. Cardiovascular X-ray Devices
- 3.2.2. Breast Imaging Market
  - 3.2.2.1. Mammography
  - 3.2.2.1.1. Computed Radiography Mammography Devices
  - 3.2.2.1.2. Digital Radiography Mammography Devices
  - 3.2.2.1.3. Digital Breast Tomosynthesis Devices
  - 3.2.2.2. Molecular Breast Imaging
  - 3.2.2.2.1. Positron Emission Mammography Devices
  - 3.2.2.2.2. Gamma Imaging Devices
  - 3.2.2.3. Breast Ultrasound
  - 3.2.2.4. MRI Coil Market
- 3.2.3. Magnetic Resonance Imaging Market
  - 3.2.3.1. Closed-Bore vs. Wide-Bore Systems
- 3.2.4. Ultrasound Imaging Market
  - 3.2.4.1. Cardiology Ultrasound Devices
  - 3.2.4.2. Radiology Ultrasound Devices
  - 3.2.4.3. OB/GYN Ultrasound Devices
  - 3.2.4.4. Urology Ultrasound Devices
  - 3.2.4.5. Surgery Ultrasound Devices
  - 3.2.4.6. Vascular Ultrasound Devices
  - 3.2.4.7. Ophthalmic Ultrasound Devices
  - 3.2.4.8. Point-of-Care Ultrasound Imaging Devices
- 3.2.5. Computed Tomography Imaging Market
- 3.2.6. Nuclear Medicine Imaging Market
  - 3.2.6.1. PET/CT
  - 3.2.6.2. SPECT
  - 3.2.6.3. SPECT/CT Devices
- 3.2.7. Contrast Agent and Injector Market
  - 3.2.7.1. X-ray and CT
  - 3.2.7.2. MRI
  - 3.2.7.3. Ultrasound
  - 3.2.7.4. Contrast Injector
3.3. REGULATORY ISSUES AND RECALLS
- 3.3.1. X-ray Imaging Market FDA Recalls
- 3.3.2. Breast Imaging Market FDA Recalls
- 3.3.3. Magnetic Resonance Imaging Market FDA Recalls
- 3.3.4. Ultrasound Imaging Market FDA Recalls
- 3.3.5. Computed Tomography Imaging Market FDA Recalls
- 3.3.6. Nuclear Medicine Imaging Market FDA Recalls
- 3.3.7. Contrast Agent and Injector Market FDA Recalls
3.4. CLINICAL TRIALS
- 3.4.1. X-ray Imaging Market Clinical Trials
- 3.4.2. Breast Imaging Market Clinical Trials
- 3.4.3. Magnetic Resonance Imaging Market Clinical Trials
- 3.4.4. Ultrasound Imaging Market Clinical Trials
- 3.4.5. Computed Tomography Imaging Market Clinical Trials
- 3.4.6. Nuclear Medicine Imaging Market Clinical Trials
- 3.4.7. Contrast Agent and Injector Market Clinical Trials

U.S. MEDICAL IMAGING MARKET OVERVIEW

4.1. INTRODUCTION
4.2. MARKET OVERVIEW & TREND ANALYSIS
4.3. DRIVERS AND LIMITERS
- 4.3.1. Market Drivers
- 4.3.2. Market Limiters
4.4. COMPETITIVE MARKET SHARE ANALYSIS
4.5. MERGERS AND ACQUISITIONS
4.6. COMPANY PROFILES
- 4.6.1. Bayer
- 4.6.2. Canon Medical
- 4.6.3. Fujifilm
- 4.6.4. GE Healthcare
- 4.6.5. Hologic
- 4.6.6. Philips Healthcare
- 4.6.7. Siemens Healthineers
4.7. SWOT ANALYSIS
- 4.7.1. Bayer
- 4.7.2. Canon Medical
- 4.7.3. Fujifilm
- 4.7.4. GE Healthcare
- 4.7.5. Hologic
- 4.7.6. Philips Healthcare
- 4.7.7. Siemens Healthineers

PROCEDURE NUMBERS

5.1. INTRODUCTION
5.2. PROCEDURES
- 5.2.1. X-ray Procedures
  - 5.2.1.1. Diagnostic X-ray Procedures by Anatomy
  - 5.2.1.2. Fluoroscopy Procedures by Type
  - 5.2.1.3. Cardiovascular X-ray Procedures by Type
- 5.2.2. Breast Imaging Procedures
- 5.2.3. Magnetic Resonance Imaging Procedures
  - 5.2.3.1. Diagnostic Magnetic Resonance Imaging Procedures
  - 5.2.3.2. Magnetic Resonance Angiography Procedures
  - 5.2.3.3. Guidance Magnetic Resonance Imaging Procedures
  - 5.2.3.4. Intraoperative Magnetic Resonance Imaging Procedures
- 5.2.4. Ultrasound Procedures
  - 5.2.4.1. Ultrasound Procedures
  - 5.2.4.1.1. Cardiac Ultrasound Procedures by Type
  - 5.2.4.2. Ultrasound Guidance Procedures
- 5.2.5. Computed Tomography Procedures
  - 5.2.5.1. Diagnostic Computed Tomography Procedures by Anatomy
  - 5.2.5.2. Computed Tomography Angiography Procedures
  - 5.2.5.3. Computed Tomography Guidance Procedures
- 5.2.6. Nuclear Medicine Procedures
  - 5.2.6.1. SPECT Procedures by Anatomy
  - 5.2.6.2. PET Procedures by Anatomy

X-RAY IMAGING MARKET

6.1. INTRODUCTION
6.2. MARKET OVERVIEW
6.3. MARKET ANALYSIS AND FORECAST
- 6.3.1. Total X-ray Market
- 6.3.2. Analog X-ray Market
- 6.3.3. Computed Radiography X-ray Market
- 6.3.4. Digital Radiography X-ray Market
- 6.3.5. Fluoroscopy X-ray Market
- 6.3.6. Cardiovascular X-ray Market
6.4. DRIVERS AND LIMITERS
- 6.4.1. Market Drivers
- 6.4.2. Market Limiters
6.5. COMPETITIVE MARKET SHARE ANALYSIS

BREAST IMAGING MARKET

7.1. INTRODUCTION
7.2. MARKET OVERVIEW
7.3. MARKET ANALYSIS AND FORECAST
- 7.3.1. Total Mammography Market
  - 7.3.1.1. Computed Radiography Market
  - 7.3.1.2. Digital Radiography Market
  - 7.3.1.3. Digital Tomosynthesis Market
- 7.3.2. Total Molecular Breast Imaging Market
  - 7.3.2.1. Positron Emission Mammography Market
  - 7.3.2.2. Gamma Imaging Market
- 7.3.3. Total Breast Ultrasound Market
  - 7.3.3.1. Manual Breast Ultrasound Market
  - 7.3.3.2. Automated Breast Ultrasound Market
- 7.3.4. MRI Coil Market
7.4. DRIVERS AND LIMITERS
- 7.4.1. Market Drivers
- 7.4.2. Market Limiters
7.5. COMPETITIVE MARKET SHARE ANALYSIS

MAGNETIC RESONANCE IMAGING MARKET

8.1. INTRODUCTION
8.2. MARKET OVERVIEW
8.3. MARKET ANALYSIS AND FORECAST
- 8.3.1. Total Closed-Bore MRI Market
  - 8.3.1.1. Low-Field Closed-Bore MRI Market
  - 8.3.1.2. Mid-Field Closed-Bore MRI Market
  - 8.3.1.3. High-Field Closed-Bore MRI Market
- 8.3.2. Total Wide-Bore MRI Market
  - 8.3.2.1. Low-Field Wide-Bore MRI Market
  - 8.3.2.2. Mid-Field Wide-Bore MRI Market
  - 8.3.2.3. High-Field Wide-Bore MRI Market
8.4. DRIVERS AND LIMITERS
- 8.4.1. Market Drivers
- 8.4.2. Market Limiters
8.5. COMPETITIVE MARKET SHARE ANALYSIS

ULTRASOUND IMAGING MARKET

9.1. INTRODUCTION
9.2. MARKET OVERVIEW
9.3. MARKET ANALYSIS AND FORECAST
- 9.3.1. Total Ultrasound Imaging Market
- 9.3.2. Cardiology Ultrasound Market
  - 9.3.2.1. Cardiology Ultrasound Market by Type
  - 9.3.2.1.1. High-End Cardiology Ultrasound Market
  - 9.3.2.1.2. Hand-Carried Cardiology Ultrasound Market
  - 9.3.2.2. Cardiology Ultrasound Market by Setting
  - 9.3.2.2.1. Hospital Cardiology Ultrasound Market
  - 9.3.2.2.2. Office Cardiology Ultrasound Market
- 9.3.3. Radiology Ultrasound Market
  - 9.3.3.1. Radiology Ultrasound Market by Type
  - 9.3.3.1.1. High-End Radiology Ultrasound Market
  - 9.3.3.1.2. Hand-Carried Radiology Ultrasound Market
  - 9.3.3.2. Radiology Ultrasound Market by Setting
  - 9.3.3.2.1. Hospital Radiology Ultrasound Market
  - 9.3.3.2.2. Office Radiology Ultrasound Market
- 9.3.4. Obstetrics and Gynecology Ultrasound Market
  - 9.3.4.1. Obstetrics and Gynecology Ultrasound Market by Type
  - 9.3.4.1.1. High-End Obstetrics and Gynecology Ultrasound Market
  - 9.3.4.1.2. Hand-Carried Obstetrics and Gynecology Ultrasound Market
  - 9.3.4.2. Obstetrics and Gynecology Ultrasound Market by Setting
  - 9.3.4.2.1. Hospital Obstetrics and Gynecology Ultrasound Market
  - 9.3.4.2.2. Office Obstetrics and Gynecology Ultrasound Market
- 9.3.5. Urology Ultrasound Market
  - 9.3.5.1. Urology Ultrasound Market by Type
  - 9.3.5.1.1. High-End Urology Ultrasound Market
  - 9.3.5.1.2. Hand-Carried Urology Ultrasound Market
  - 9.3.5.2. Urology Ultrasound Market by Setting
  - 9.3.5.2.1. Hospital Urology Ultrasound Market
  - 9.3.5.2.2. Office Urology Ultrasound Market
- 9.3.6. Surgery Ultrasound Market
- 9.3.7. Vascular Ultrasound Market
- 9.3.8. Ophthalmic Ultrasound Market
  - 9.3.8.1. Pachymeter Ophthalmic Ultrasound Market
  - 9.3.8.2. A-Scan Ultrasound Market
  - 9.3.8.3. B-Scan Ultrasound Market
  - 9.3.8.4. A/B Scan Ultrasound Market
  - 9.3.8.5. Ultrasound Biomicroscope Market
- 9.3.9. Point-of-Care Ultrasound Market
  - 9.3.9.1. Emergency Medicine Point-of-Care Ultrasound Imaging
  - 9.3.9.1.1. Emergency Medicine Point-of-Care Ultrasound by Device Type
  - 9.3.9.2. Total Anesthesia Ultrasound Market
  - 9.3.9.2.1. Anesthesia Ultrasound Equipment Market by Type
  - 9.3.9.2.2. Anesthesia Ultrasound Equipment Market by Function
  - 9.3.9.3. Critical Care Ultrasound Market
  - 9.3.9.3.1. Critical Care Ultrasound Market by Type
  - 9.3.9.4. Musculoskeletal Ultrasound Market
  - 9.3.9.5. Other Point-of-Care Ultrasound Market
9.4. DRIVERS AND LIMITERS
- 9.4.1. Market Drivers
- 9.4.2. Market Limiters
9.5. COMPETITIVE MARKET SHARE ANALYSIS

COMPUTED TOMOGRAPHY IMAGING MARKET

10.1. INTRODUCTION
10.2. MARKET OVERVIEW
10.3. MARKET ANALYSIS AND FORECAST
- 10.3.1. Total Computed Tomography Imaging Market
- 10.3.2. 16/20 Slice Market
- 10.3.3. 32/40 Slice Market
- 10.3.4. 64 Slice Market
- 10.3.5. Ultra-Premium Slice Market
10.4. DRIVERS AND LIMITERS
- 10.4.1. Market Drivers
- 10.4.2. Market Limiters
10.5. COMPETITIVE MARKET SHARE ANALYSIS

NUCLEAR MEDICINE IMAGING MARKET

11.1. INTRODUCTION
11.2. MARKET OVERVIEW
11.3. MARKET ANALYSIS AND FORECAST
- 11.3.1. PET/CT Nuclear Medicine Imaging Market
- 11.3.2. SPECT Nuclear Medicine Imaging Market
- 11.3.3. SPECT/CT Nuclear Medicine Imaging Market
11.4. DRIVERS AND LIMITERS
- 11.4.1. Market Drivers
- 11.4.2. Market Limiters
11.5. COMPETITIVE MARKET SHARE ANALYSIS

CONTRAST AGENT AND INJECTOR IMAGING MARKET

12.1. INTRODUCTION
12.2. MARKET OVERVIEW
12.3. MARKET ANALYSIS AND FORECAST
- 12.3.1. Total Contrast Agent Market
  - 12.3.1.1. X-ray/CT Contrast Agent Market
  - 12.3.1.2. MRI Contrast Agent Market
  - 12.3.1.3. Ultrasound Contrast Agent Market
- 12.3.2. Contrast Injector Market
12.4. DRIVERS AND LIMITERS
- 12.4.1. Market Drivers
- 12.4.2. Market Limiters
12.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Product Code: iDATA_USIMG24

LIST OF CHARTS

Chart 1 1: Medical Imaging Market by Segment, U.S., 2023 - 2030
Chart 1 2: Medical Imaging Market Overview, U.S., 2023 & 2030
Chart 2 1: Multi-Scenario U.S. Medical Imaging Market Forecast, U.S., 2020 - 2030 (US$M)
Chart 4 1: Leading Competitors, U.S. Medical Imaging Market, U.S., 2023
Chart 5 1: U.S. Medical Imaging Procedures by Segment, U.S., 2020 - 2030
Chart 6 1: X-ray Imaging Market by Segment, U.S., 2020 - 2030
Chart 6 2: Leading Competitors, X-ray Market, U.S., 2023
Chart 7 1: Breast Imaging Market by Type, U.S., 2020 - 2030
Chart 7 2: Leading Competitors, Breast Imaging Market, U.S., 2023
Chart 8 1: MRI Market by Type, U.S., 2020 - 2030
Chart 8 2: Leading Competitors, Magnetic Resonance Imaging Market, U.S., 2023
Chart 9 1: Ultrasound Market, U.S., 2020 - 2030
Chart 9 2: Leading Competitors, Breast Imaging Market, U.S., 2023
Chart 10 1: Computed Tomography Imaging Market by Type, U.S., 2020 - 2030
Chart 10 2: Leading Competitors, Computed Tomography Market, U.S., 2023
Chart 11 1: Nuclear Medicine Imaging Market by Type, U.S., 2020 - 2030
Chart 11 2: Leading Competitors, Nuclear Medicine Imaging Market, U.S., 2023
Chart 12 1: Contrast Agent and Injector Market by Segment by Type, U.S., 2020 - 2030
Chart 12 2: Leading Competitors, Computed Tomography Market, U.S., 2023

LIST OF FIGURES

Figure 1 1: Medical Imaging Market Share Ranking by Segment, U.S., 2023 (1 of 2)
Figure 1 2: Medical Imaging Market Share Ranking by Segment, U.S., 2023 (2 of 2)
Figure 1 3: Companies Researched in This Report
Figure 1 4: Factors Impacting the Medical Imaging Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Medical Imaging Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the U.S. Medical Imaging Market, U.S., 2019 - 2023 (1 of 2)
Figure 1 7: Recent Events in the U.S. Medical Imaging Market, U.S., 2019 - 2023 (2 of 2)
Figure 1 8: U.S. Medical Imaging Procedures Covered (1 of 4)
Figure 1 9: U.S. Medical Imaging Procedures Covered (2 of 4)
Figure 1 10: U.S. Medical Imaging Procedures Covered (3 of 4)
Figure 1 11: U.S. Medical Imaging Procedures Covered (4 of 4)
Figure 1 12: Procedure Codes Investigated (1 of 3)
Figure 1 13: Procedure Codes Investigated (2 of 3)
Figure 1 14: Procedure Codes Investigated (3 of 3)
Figure 1 15: U.S. Medical Imaging Markets Covered (1 of 3)
Figure 1 16: U.S. Medical Imaging Markets Covered (2 of 3)
Figure 1 17: U.S. Medical Imaging Markets Covered (3 of 3)
Figure 1 18: Key Report Updates
Figure 1 19: Version History
Figure 2 1: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
Figure 2 2: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
Figure 2 3: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
Figure 2 4: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
Figure 2 5: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (1 of 2)
Figure 2 6: U.S. Medical Imaging Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M) (2 of 2)
Figure 3 1: Analog X-ray Devices by Company
Figure 3 2: Computed Radiography X-ray Devices by Company
Figure 3 3: Digital Radiography X-ray Devices by Company (1 of 2)
Figure 3 4: Digital Radiography X-ray Devices by Company (2 of 2)
Figure 3 5: Fluoroscopy Devices by Company (1 of 2)
Figure 3 6: Fluoroscopy Devices by Company (2 of 2)
Figure 3 7: Cardiovascular X-ray Devices by Company
Figure 3 8: Computed Radiography Mammography Devices by Company
Figure 3 9: Digital Radiography Mammography Devices by Company
Figure 3 10: Digital Breast Tomosynthesis Devices by Company
Figure 3 11: Positron Emission Mammography Devices by Company
Figure 3 12: Gamma Imaging Devices by Company
Figure 3 13: Breast Ultrasound Devices by Company
Figure 3 14: MRI Coil Market by Company
Figure 3 15: Magnetic Resonance Imaging Market by Company (1 of 2)
Figure 3 16: Magnetic Resonance Imaging Market by Company (2 of 2)
Figure 3 17: Cardiology Ultrasound Devices by Company
Figure 3 18: Radiology Ultrasound Devices by Company
Figure 3 19: OB/GYN Ultrasound Devices by Company (1 of 2)
Figure 3 20: OB/GYN Ultrasound Devices by Company (2 of 2)
Figure 3 21: Urology Ultrasound Devices by Company
Figure 3 22: Surgery Ultrasound Devices by Company
Figure 3 23: Vascular Ultrasound Devices by Company
Figure 3 24: Ophthalmic Ultrasound Devices by Company
Figure 3 25: Point-of-Care Ultrasound Imaging Devices by Company
Figure 3 26: Computed Tomography Imaging Market by Company
Figure 3 27: PET/CT Devices by Company
Figure 3 28: SPECT Devices by Company
Figure 3 29: SPECT/CT Devices by Company
Figure 3 30: 1.2.7 X-ray and CT Contrast Agent and Injector by Company
Figure 3 31: MRI Contrast Agent and Injector by Company
Figure 3 32: Ultrasound Contrast Agent and Injector by Company
Figure 3 33: Contrast Injector by Company
Figure 3 34: Class 2 Device Recall Philips Allura Xper, Allura Centron, Allura CV, Azurion, UNIQ Clarity, and MultiDiagnostEleva System
Figure 3 35: Class 2 Device Recall DigitalDiagnost C90
Figure 3 36: Class 2 Device Recall Philips
Figure 3 37: Class 2 Device Recall FDR AQRO (DRXD 1000)
Figure 3 38: Class 2 Device Recall Luminos Agile Max
Figure 3 39: Class 2 Device Recall Luminos dRF Max, Luminos Agile Max, Uroskop Omnia Max, Multitom Rax
Figure 3 40: Class 2 Device Recall DigitalDiagnost C50
Figure 3 41: Class 2 Device Recall DigitalDiagnost C90
Figure 3 42: Class 2 Device Recall DigitalDiagnost
Figure 3 43: Class 2 Device Recall ProxiDiagnost N90
Figure 3 44: Class 2 Device Recall Omnera
Figure 3 45: Class 2 Device Recall Interventional Fluoroscopic Xray System
Figure 3 46: Class 2 Device Recall DR 800 with MUSICA Dynamic
Figure 3 47: Class 2 Device Recall Agfa DR 800
Figure 3 48: Class 2 Device Recall Ysio Max
Figure 3 49: Class 2 Device Recall Ysio Max
Figure 3 50: Class 2 Device Recall Cardio Vascular Allura Centron Interventional Fluoroscopic Xray System
Figure 3 51: Class 2 Device Recall Fujifilm FDR Go Plus Mobile Xray System
Figure 3 52: Class 2 Device Recall AGFA Digital Radiography X Ray System DR 800
Figure 3 53: Class 2 Device Recall Hologic
Figure 3 54: Class 2 Device Recall EPIQ Ultrasound Systems, Model: EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EP
Figure 3 55: Class 2 Device Recall Philips EPIQ Diagnostic Ultrasound System
Figure 3 56: Class 2 Device Recall MAMMOMAT Revelation
Figure 3 57: Class 2 Device Recall Selenia Dimensions Mammography System
Figure 3 58: Class 2 Device Recall MAMMOMAT Revelation
Figure 3 59: Class 2 Device Recall GE Senographe Pristina
Figure 3 60: Class 2 Device Recall Philips Ingenia Elition S
Figure 3 61: Class 2 Device Recall Philips Ingenia Elition X
Figure 3 62: Class 2 Device Recall SIGNA Premier
Figure 3 63: Class 2 Device Recall GE Healthcare MR Systems.
Figure 3 64: Class 2 Device Recall Signa 1.5T TwinSpeed
Figure 3 65: Class 2 Device Recall 1.5T SIGNA Excite HD, 3.0T SIGNA Excite HD
Figure 3 66: Class 2 Device Recall SIGNA Excite 3T
Figure 3 67: Class 2 Device Recall 1.5T and 3.0T SIGNA HDx, 1.5T and 3.0T SIGNA HDxt, and 1.5T SIGNA HDxt Mobile
Figure 3 68: Class 2 Device Recall SIGNA Architect
Figure 3 69: Class 2 Device Recall SIGNA Artist
Figure 3 70: Class 2 Device Recall SIGNA Creator, SIGNA Explorer
Figure 3 71: Class 2 Device Recall SIGNA Voyager
Figure 3 72: Class 2 Device Recall SIGNA Pioneer
Figure 3 73: Class 2 Device Recall SIGNA Premier
Figure 3 74: Class 2 Device Recall SIGNA Premier
Figure 3 75: Class 2 Device Recall SIGNA Artist
Figure 3 76: Class 2 Device Recall SIGNA Architect
Figure 3 77: Class 2 Device Recall SIGNA Pioneer
Figure 3 78: Class 2 Device Recall SIGNA Voyager
Figure 3 79: Class 2 Device Recall SIGNA Creator, SIGNA Explorer
Figure 3 80: Class 2 Device Recall SIGNA MR355, SIGNA MR360
Figure 3 81: Class 2 Device Recall Vantage Galan 3T
Figure 3 82: Class 2 Device Recall ACUSON Redwood Systems with Software Version 2.0
Figure 3 83: Class 2 Device Recall GE Healthcare Vivid
Figure 3 84: Class 2 Device Recall NovaGuide Intelligent Ultrasound System
Figure 3 85: Class 2 Device Recall Vivid S5
Figure 3 86: Class 2 Device Recall Vivid S5 N
Figure 3 87: Class 2 Device Recall Vivid S6
Figure 3 88: Class 2 Device Recall Vivid S6 N
Figure 3 89: Class 2 Device Recall Vivid q
Figure 3 90: Class 2 Device Recall Vivid q N
Figure 3 91: Class 2 Device Recall Vivid i
Figure 3 92: Class 2 Device Recall Vivid i N
Figure 3 93: Class 2 Device Recall Canon Aplio Ultrasound System
Figure 3 94: Class 2 Device Recall ACUSON Juniper Diagnostic Ultrasound System
Figure 3 95: Class 2 Device Recall ACUSON Sequoia Ultrasound Imaging System
Figure 3 96: Class 2 Device Recall Fujifilm
Figure 3 97: Class 2 Device Recall EPIQ CVxi Diagnostic Ultrasound Systems
Figure 3 98: Class 2 Device Recall Philips EPIQ Diagnostic Ultrasound Systems
Figure 3 99: Class 2 Device Recall Philips Afiniti Diagnostic Ultrasound Systems
Figure 3 100: Class 2 Device Recall EPIQ Ultrasound Systems, Model: EPIQ Elite, EPIQ 5G, EPIQ 5C, EPIQ 5W, EPIQ 7G, EPIQ 7C, EPIQ 7W, EP
Figure 3 101: Class 2 Device Recall ACUSON Juniper ultrasound imaging system
Figure 3 102: Class 2 Device Recall Philips Incisive CT
Figure 3 103: Class 2 Device Recall Philips
Figure 3 104: Class 2 Device Recall Spectral CT 7500
Figure 3 105: Class 2 Device Recall Incisive CT
Figure 3 106: Class 2 Device Recall SOMATOM Confidence
Figure 3 107: Class 2 Device Recall SOMATOM Edge Plus
Figure 3 108: Class 2 Device Recall SOMATOM Definition AS
Figure 3 109: Class 2 Device Recall SOMATOM Definition Edge
Figure 3 110: Class 2 Device Recall Siemens
Figure 3 111: Class 2 Device Recall Revolution CT, Revolution CT ES, Revolution Apex, Revolution CT with Apex Edition
Figure 3 112: Class 2 Device Recall Philips
Figure 3 113: Class 2 Device Recall Revolution CT with Apex Edition CT System
Figure 3 114: Class 2 Device Recall Biograph mCT, Biograph Horizon, Biograph Vision
Figure 3 115: Class 2 Device Recall Symbia
Figure 3 116: Class 2 Device Recall GE NM/CT 850
Figure 3 117: Class 2 Device Recall GE NM/CT 860
Figure 3 118: Class 2 Device Recall Optima NM/CT 640
Figure 3 119: Class 2 Device Recall MEDRAD Stellant FLEX Syringe Kits
Figure 3 120: Optimization of Bedside Chest X-rays Taken in the Intensive Care Unit by Using Current Software-Based Techniques
Figure 3 121: Identify Coronavirus Disease by Chest X-ray
Figure 3 122: Next Generation X-ray Imaging System
Figure 3 123: Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab
Figure 3 124: Chest X-ray in Diagnosis of Heart Failure
Figure 3 125: Comparison of Breast Cancer Screening with CESM to DBT in Women with Dense Breasts (CMIST)
Figure 3 126: Preoperative Magnetic Resonance Imaging to Obtain Adequate Resection Margins in Breast Conserving Surgery, (PRIMAR) Trial
Figure 3 127: Novel Thermal Imaging Technique for Breast Screening
Figure 3 128: An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
Figure 3 129: Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
Figure 3 130: Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis (AMELIA)
Figure 3 131: Discomfort Assessment of Senographe Pristina Patient-assisted Versus Standard Compression Mode and Quality Assessment of Screening Mammograms
Figure 3 132: Breast Density Measurements in Digital Mammography and Breast Tomosynthesis Systems of Different Pixel Size
Figure 3 133: Simulated Screening Study for Breast Imaging
Figure 3 134: Molecular Breast Imaging in Screening Breast Cancer
Figure 3 135: Evaluation of New Magnetic Resonance Techniques
Figure 3 136: New Heart Imaging Techniques to Evaluate Possible Heart Disease
Figure 3 137: Magnetic Resonance Imaging of Breast Cancer
Figure 3 138: Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
Figure 3 139: MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases
Figure 3 140: Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
Figure 3 141: A Percutaneous Ultrasound Device with Needle Guide for Vascular Access
Figure 3 142: 3D Ultrasound Breast Imaging
Figure 3 143: Ultrasound Imaging of Kidney Stones and Lithotripsy
Figure 3 144: Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones
Figure 3 145: Point of Care Ultrasound in Obstetric Triage (POCUS)
Figure 3 146: Point-of-Care Ultrasound in Primary Care (POCUS iGP 1)
Figure 3 147: Use of POC Pocket Ultrasound in the Estimation of Left and Right Atrial Pressures
Figure 3 148: Point of Care Ultrasonography
Figure 3 149: Prospective Evaluation of Myocardial Perfusion Computed Tomography Trial (PERFUSERCT)
Figure 3 150: Computed Tomography vs. Endoscopy Study
Figure 3 151: Computed Tomography Scanning in ICU
Figure 3 152: Evaluating New Radiation Techniques for Cardiovascular Imaging
Figure 3 153: 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assessment for Left Sided Breast Cancers Radiotherapy
Figure 3 154: Spectral CT Clinical Trial Protocol
Figure 3 155: Computed Tomography for COVID-19 Diagnosis
Figure 3 156: Fluorocholine PET/CT Basket Trial
Figure 3 157: SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
Figure 3 158: SPECT/CT for the Characterization of Renal Masses
Figure 3 159: Gated and Non-Gated Dynamic PET/CT Imaging
Figure 3 160: Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System
Figure 3 161: Evaluation of a New Generation of PET-CT OMNI
Figure 3 162: Demonstration of a Next Generation PET CT System
Figure 3 163: Standard PET/CT vs. Digital PET/CT
Figure 3 164: Radio-opaque Contrast Agents for Liver Cancer Targeting with KIM During Radiation Therapy (ROCK-RT)
Figure 3 165: Dotarem vs Gadobutrol Contrast for Breast MRI
Figure 3 166: Chest CT Using Low-Concentration Iodine Contrast Media
Figure 3 167: A Study Called GUS to Understand How Much of the Contrast Agent Gadavist Is Used and How Much Is Wasted in Two Different Containers (Single-Dose Vials and Imaging Bulk Packages) in a Real-World Setting
Figure 3 168: Negative Oral Contrast Agents Utilization in PET/CT Studies
Figure 4 1: U.S. Medical Imaging Market by Segment, U.S., 2020 - 2030 (US$M) (1 of 2)
Figure 4 2: U.S. Medical Imaging Market by Segment, U.S., 2020 - 2030 (US$M) (2 of 2)
Figure 4 3: Leading Competitors, U.S. Medical Imaging Market, U.S., 2023 (1 of 2)
Figure 4 4: Leading Competitors, U.S. Medical Imaging Market, U.S., 2023 (2 of 2)
Figure 4 5: SWOT Analysis, Bayer
Figure 4 6: SWOT Analysis, Canon Medical
Figure 4 7: SWOT Analysis, Fujifilm
Figure 4 8: SWOT Analysis, Hologic
Figure 5 1: Procedure Codes Investigated (1 of 3)
Figure 5 2: Procedure Codes Investigated (2 of 3)
Figure 5 3: Procedure Codes Investigated (3 of 3)
Figure 5 4: U.S. Medical Imaging Procedures by Segment, U.S., 2020 - 2030
Figure 5 5: X-ray Procedures by Segment, U.S., 2020 - 2030
Figure 5 6: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (1 of 4)
Figure 5 7: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (2 of 4)
Figure 5 8: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (3 of 4)
Figure 5 9: Diagnostic X-ray Procedures by Anatomy, U.S., 2020 - 2030 (4 of 4)
Figure 5 10: Fluoroscopy X-ray Procedures by Type, U.S., 2020 - 2030
Figure 5 11: Cardiovascular X-ray Procedures by Anatomy, U.S., 2020 - 2030
Figure 5 12: Breast Imaging Procedures by Modality, U.S., 2020 - 2030
Figure 5 13: Magnetic Resonance Imaging Procedures by Modality, U.S., 2020 - 2030
Figure 5 14: Diagnostic Magnetic Resonance Imaging Procedures by Anatomy, U.S., 2020 - 2030 (1 of 3)
Figure 5 15: Diagnostic Magnetic Resonance Imaging Procedures by Anatomy, U.S., 2020 - 2030 (2 of 3)
Figure 5 16: Diagnostic Magnetic Resonance Imaging Procedures by Anatomy, U.S., 2020 - 2030 (3 of 3)
Figure 5 17: Magnetic Resonance Angiography Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
Figure 5 18: Magnetic Resonance Angiography Procedures by Anatomy, U.S., 2020 - 2030 (2 of 2)
Figure 5 19: Guidance Magnetic Resonance Imaging Procedures, U.S., 2020 - 2030
Figure 5 20: Intraoperative Magnetic Resonance Imaging Procedures, U.S., 2020 - 2030
Figure 5 21: Ultrasound Procedures by Type, U.S., 2020 - 2030
Figure 5 22: Ultrasound Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
Figure 5 23: Ultrasound Procedures by Anatomy, U.S., 2020 - 2030 (2 of 2)
Figure 5 24: Cardiac Ultrasound Procedures, U.S. by Type, 2020 - 2030
Figure 5 25: Ultrasound Guidance Procedures, U.S., 2020 - 2030
Figure 5 26: Computed Tomography Procedures by Type, U.S., 2020 - 2030
Figure 5 27: Diagnostic Computed Tomography Procedures by Anatomy, U.S., 2020 - 2030 (1 of 3)
Figure 5 28: Diagnostic Computed Tomography Procedures by Anatomy, U.S., 2020 - 2030 (2 of 3)
Figure 5 29: Diagnostic Computed Tomography Procedures by Anatomy, U.S., 2020 - 2030 (3 of 3)
Figure 5 30: Computed Tomography Angiography Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
Figure 5 31: Computed Tomography Angiography Procedures by Anatomy, U.S., 2020 - 2030 (2 of 2)
Figure 5 32: Computed Tomography Guidance Procedures, U.S., 2020 - 2030
Figure 5 33: Nuclear Medicine Procedures by Modality, U.S., 2020 - 2030
Figure 5 34: SPECT Procedures by Anatomy, U.S., 2020 - 2030 (1 of 2)
Figure 5 35: SPECT Procedures by Modality, U.S., 2020 - 2030 (2 of 2)
Figure 5 36: PET Procedures by Anatomy, U.S., 2020 - 2030
Figure 6 1: X-ray Imaging Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 6 2: Total X-ray Market, U.S., 2020 - 2030
Figure 6 3: Analog X-ray Market, U.S., 2020 - 2030
Figure 6 4: Computed Radiography X-ray Market, U.S., 2020 - 2030
Figure 6 5: Digital Radiography X-ray Market, U.S., 2020 - 2030
Figure 6 6: Fluoroscopy Radiography X-ray Market, U.S., 2020 - 2030
Figure 6 7: Cardiovascular X-ray Market, U.S., 2020 - 2030
Figure 6 8: Leading Competitors, X-ray Market, U.S., 2023
Figure 7 1: Breast Imaging Market by Type, U.S., 2020 - 2030 (US$M)
Figure 7 2: Mammography Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 7 3: Computed Radiography Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 7 4: Digital Radiography Market, U.S., 2020 - 2030 (US$M)
Figure 7 5: Digital Tomosynthesis Market, U.S., 2020 - 2030 (US$M)
Figure 7 6: Molecular Breast Imaging Market by Type, U.S., 2020 - 2030 (US$M)
Figure 7 7: Total Molecular Breast Imaging Market, U.S., 2020 - 2030 (US$M)
Figure 7 8: Positron Emission Mammography Market, U.S., 2020 - 2030 (US$M)
Figure 7 9: Gamma Imaging Market, U.S., 2020 - 2030 (US$M)
Figure 7 10: Ultrasound Breast Imaging Market by Type, U.S., 2020 - 2030 (US$M)
Figure 7 11: Total Breast Ultrasound, U.S., 2020 - 2030
Figure 7 12: Manual Breast Market, U.S., 2020 - 2030 (US$M)
Figure 7 13: Automated Breast Ultrasound Market, U.S., 2020 - 2030 (US$M)
Figure 7 14: MRI Coil Market, U.S., 2020 - 2030
Figure 7 15: Leading Competitors, Breast Imaging Market, U.S., 2023
Figure 8 1: MRI Market by Type, U.S., 2020 - 2030 (US$M)
Figure 8 2: Total Closed-Bore MRI Market by Segment, 2020 - 2030 (US$M)
Figure 8 3: Low-Field Closed-Bore MRI Market, U.S., 2020 - 2030
Figure 8 4: Mid-Field Closed-bore MRI Market, U.S., 2020 - 2030
Figure 8 5: High-Field Closed-Bore MRI Market, U.S., 2020 - 2030
Figure 8 6: Total Wide-Bore MRI Market by Segment, 2020 - 2030 (US$M)
Figure 8 7: Low-Field Wide-Bore MRI Market, U.S., 2020 - 2030
Figure 8 8: Mid-Field Wide-Bore MRI Market, U.S., 2020 - 2030
Figure 8 9: High-Field Wide-Bore MRI Market, U.S., 2020 - 2030
Figure 8 10: Leading Competitors, Magnetic Resonance Imaging Market, U.S., 2023
Figure 9 1: Ultrasound Market by Type, U.S., 2020 - 2030 (US$M) (1 of 2)
Figure 9 2: Ultrasound Market by Type, U.S., 2020 - 2030 (US$M) (2 of 2)
Figure 9 3: Total Ultrasound Imaging Market, U.S., 2020 - 2030
Figure 9 4: Cardiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 5 High-End Cardiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 6 Hand Carried Cardiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 7 Hospital Cardiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 8 Office Cardiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 9: Radiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 10 High-End Radiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 11 Hand Carried Radiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 12 Hospital Radiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 13 Office Radiology Ultrasound Market, U.S., 2020 - 2030
Figure 9 14: Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
Figure 9 15 High-End Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
Figure 9 16 Hand Carried Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
Figure 9 17 Hospital Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
Figure 9 18 Office Obstetrics and Gynecology Ultrasound Market, U.S., 2020 - 2030
Figure 9 19: Urology Ultrasound Market, U.S., 2020 - 2030
Figure 9 20 High-End Urology Ultrasound Market, U.S., 2020 - 2030
Figure 9 21 Hand Carried Urology Ultrasound Market, U.S., 2020 - 2030
Figure 9 22 Hospital Urology Ultrasound Market, U.S., 2020 - 2030
Figure 9 23 Office Urology Ultrasound Market, U.S., 2020 - 2030
Figure 9 24: Surgery Ultrasound Market, U.S., 2020 - 2030
Figure 9 25: Vascular Ultrasound Market, U.S., 2020 - 2030
Figure 9 26: Ophthalmic Ultrasound Equipment Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 9 27: Total Ophthalmic Ultrasound Market, U.S., 2020 - 2030
Figure 9 28: Pachymeter Ultrasound Market, U.S., 2020 - 2030
Figure 9 29: A-Scan Ultrasound Market, U.S., 2020 - 2030
Figure 9 30: B-Scan Ultrasound Market, U.S., 2020 - 2030
Figure 9 31: A/B Scan Ultrasound Market, U.S., 2020 - 2030
Figure 9 32: Ultrasound Biomicroscope Market, U.S., 2020 - 2030
Figure 9 33: Point-of-Care Ultrasound Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 9 34: Total Point-of-Care Ultrasound Market, U.S., 2020 - 2030
Figure 9 35: Emergency Medicine Ultrasound Market, U.S., 2020 - 2030
Figure 9 36 Hand Carried Emergency Medicine Ultrasound Market, U.S., 2020 - 2030
Figure 9 37 Cart-Based Emergency Medicine Ultrasound Market, U.S., 2020 - 2030
Figure 9 38: Total Anesthesia Ultrasound Market, U.S., 2020 - 2030
Figure 9 39 Hand-Carried Anesthesia Ultrasound Market, U.S., 2020 - 2030
Figure 9 40 Cart-Based Anesthesia Ultrasound Market, U.S., 2020 - 2030
Figure 9 41 Regional Anesthesia Ultrasound Market, U.S., 2020 - 2030
Figure 9 42 General Anesthesia Ultrasound Market, U.S., 2020 - 2030
Figure 9 43: Critical Care Ultrasound Market, U.S., 2020 - 2030
Figure 9 44 Hand-Carried Critical Care Ultrasound Market, U.S., 2020 - 2030
Figure 9 45 Cart-Based Critical Care Ultrasound Market, U.S., 2020 - 2030
Figure 9 46: Musculoskeletal Ultrasound Market, U.S., 2020 - 2030
Figure 9 47: Other Point-of-Care Ultrasound Market, U.S., 2020 - 2030
Figure 9 48: Leading Competitors, Ultrasound Imaging Market, U.S., 2023 (1 of 2)
Figure 9 49: Leading Competitors, Ultrasound Imaging Market, U.S., 2023 (2 of 2)
Figure 10 1: Computed Tomography Imaging Market by Type, U.S., 2020 - 2030 (US$M)
Figure 10 2: Total Computed Tomography Imaging Market, U.S., 2020 - 2030
Figure 10 3: 16/20 Slice Market, U.S., 2020 - 2030
Figure 10 4: 32/40 Slice Market, U.S., 2020 - 2030
Figure 10 5: 64 Slice Market, U.S., 2020 - 2030
Figure 10 6: Ultra-Premium Slice Market, U.S., 2020 - 2030
Figure 10 7: Leading Competitors, Computed Tomography Imaging Market, U.S., 2023
Figure 11 1: Nuclear Medicine Imaging Market by Type, U.S., 2020 - 2030 (US$M)
Figure 11 2: PET/CT Nuclear Medicine Imaging Market, U.S., 2020 - 2030
Figure 11 3: SPECT Nuclear Medicine Imaging Market, U.S., 2020 - 2030
Figure 11 4: SPECT/CT Nuclear Medicine Imaging Market, U.S., 2020 - 2030
Figure 11 5: Leading Competitors, Nuclear Medicine Imaging Market, U.S., 2023
Figure 12 1: Contrast Agent and Injector Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 12 2: Total Contrast Agents by Segment, U.S., 2020 - 2030 (US$M)
Figure 12 3: X-ray/CT Contrast Agent Market, U.S., 2020 - 2030
Figure 12 4: MRI Contrast Agent Market, U.S., 2020 - 2030
Figure 12 5: Ultrasound Contrast Agent Market, U.S., 2020 - 2030
Figure 12 6: Contrast Injector Market, U.S., 2020 - 2030
Figure 12 7: Leading Competitors, Computed Tomography Imaging Market, U.S., 2023